GlassScriptPhysician profile
Matthew Hadilaksono
NPI 1205225174
$4,646.90
in general payments reported to CMS, 2019-2025
19 companies · $788 in 2025
The $788 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $957 · 2020: $644 · 2021: $204 · 2022: $774 · 2023: $511 · 2024: $770 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,398.30 | 2019-2025 | Eterna, Proclaim, Axium |
| Spr Therapeutics, INC | $666.92 | 2022-2025 | Sprint Pns System |
| Boston Scientific Corporation | $445.88 | 2020-2025 | Intracept, General - Pain Management |
| Abbvie INC. | $263.30 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $131.35 | 2025 | Cobenfy |
| Amgen INC. | $128.65 | 2019 | |
| Indivior INC. | $126.84 | 2019-2022 | |
| Nevro Corp. | $125.31 | 2019 | |
| Nalu Medical, INC. | $72.53 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $49.56 | 2025 | |
| Fidia Pharma USA INC. | $38.80 | 2022 | |
| Avanos Medical | $36.16 | 2023-2024 | Genvisc 850 Sodium Hyaluronate |
| Medtronic, INC. | $28.96 | 2023 | Intellis Adaptivestim |
| Painteq LLC | $25.29 | 2022 | |
| Stimwave Technologies Incorporated | $25.10 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $22.04 | 2023 | Ztlido |
| Si-Bone, INC. | $21.92 | 2024 | |
| Djo, LLC | $20.45 | 2023 | Procare |
| Averitas Pharma INC. | $19.54 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hadilaksono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.